➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Harvard Business School
Colorcon
McKinsey
Medtronic

Last Updated: July 11, 2020

DrugPatentWatch Database Preview

Piperazine citrate - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

Summary for piperazine citrate
US Patents:0
Tradenames:5
Applicants:8
NDAs:8
Drug Master File Entries: 18
Bulk Api Vendors: 42
Patent Applications: 138
DailyMed Link:piperazine citrate at DailyMed

US Patents and Regulatory Information for piperazine citrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline ANTEPAR piperazine citrate SYRUP;ORAL 009102-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Luitpold PIPERAZINE CITRATE piperazine citrate SYRUP;ORAL 080671-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Bluline MULTIFUGE piperazine citrate SYRUP;ORAL 009452-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Impax Labs PIPERAZINE CITRATE piperazine citrate TABLET;ORAL 080874-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Solvay VERMIDOL piperazine citrate SYRUP;ORAL 080992-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Glaxosmithkline ANTEPAR piperazine citrate TABLET;ORAL 009102-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Sanofi Aventis Us BRYREL piperazine citrate SYRUP;ORAL 017796-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Harvard Business School
Colorcon
McKinsey
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.